Upcoming Special Issue of Pharmaceutical Regulatory Affairs: Open Access

Upcoming Special Issue

Purpose: To publish the most exciting research with respect to the subjects of Pharmaceutical Regulatory Affairs: Open Access and to provide a rapid turn-around time regarding reviewing and publishing, and to disseminate the articles freely for research, teaching and reference purposes.

Special Issue Topics

Special issue entitled: Bio pharmaceutics and Regulatory affairs is being edited by

Biography

Manfred Kurz
Generics company
Switzerland

Special issue entitled: Screening of New Drugs from Natural Products is being edited by

Biography

Ana Lucia Abujamra
Department of Pharmacology
Federal University of Rio Grande, Brazil
Tel: +55-51-9999-8129
Fax: +51-3388-2877

Special issue entitled: Drug Regulation Policy is being edited by

Biography

Manfred Kurz
Generics company
Switzerland

Special issue entitled: Extractables and Leachables from Drug and/or Medical Devices is being edited by

Biography

Executive Editor Hideharu Shintani
Department of Chemistry
Chuo University
Japan

Special issue entitled: Botanical Drugs: Different Regulatory Approaches is being edited by

Biography

Mohamed Eddouks
Professor
Moulay Ismail University
Morocco
Tel. +212535573240
Fax +212535573240

Special issue entitled: New Therapeutic Approaches in Treating Cancer is being edited by

Biography

Fabio Grizzi
Laboratory of Molecular Gastroenterology
Humanitas Clinical and Research Center
Rozzano, Milan, Italy

Special issue entitled: "Pharmaceutical Good Manufacturing Practice Regulatory Affairs" (Released)

Submission Process

Submit Special Issue articles online through manuscript submission, review and editorial tracking system for quality and quick review processing at https://www.hilarispublisher.com/pharmaceutical-regulatory-affairs-open-access/submit-manuscript.html or send as an e-mail attachment to the editorial office at [email protected]

Note:

In case of online submission, please select "Special Issue Article" from the dropdown list.
In case of e-mail, please specify the title of the special issue in the subject and in the cover letter of the submission.

Pharmaceutical Regulatory Affairs: Open Access